Ulrich Müller
YOU?
Author Swipe
View article: Type 2 Diabetes Mellitus Impairs the Reverse Transendothelial Migration Capacity (rTEM) of Inflammatory CD14+CD16− Monocytes: Novel Mechanism for Enhanced Subendothelial Monocyte Accumulation in Diabetes
Type 2 Diabetes Mellitus Impairs the Reverse Transendothelial Migration Capacity (rTEM) of Inflammatory CD14+CD16− Monocytes: Novel Mechanism for Enhanced Subendothelial Monocyte Accumulation in Diabetes Open
Background: Type 2 diabetes mellitus (DM) is a major cardiovascular risk factor that induces monocyte dysfunction and contributes to their accumulation in atherosclerotic lesions. Monocyte recruitment and accumulation in the tissues contri…
View article: Evaluating a Chatbot as a Companion for Patients With Breast Cancer: Collaborative Pilot Study
Evaluating a Chatbot as a Companion for Patients With Breast Cancer: Collaborative Pilot Study Open
Background Patients with breast cancer frequently experience significant uncertainty, prompting them to seek detailed, personalized, and reliable medical information to enhance adherence to prescribed treatments, medications, and recommend…
View article: POS0861 BEYOND IgG: EXPLORING THE ADDITIVE VALUE OF ANTI-MPO IgM IN ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY (ANCA)-ASSOCIATED VASCULITIS (AAV)
POS0861 BEYOND IgG: EXPLORING THE ADDITIVE VALUE OF ANTI-MPO IgM IN ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY (ANCA)-ASSOCIATED VASCULITIS (AAV) Open
View article: The SIMPATHIC Basket Trial: Targeting Shared Pathomechanisms for Personalized Medicine in Rare Diseases
The SIMPATHIC Basket Trial: Targeting Shared Pathomechanisms for Personalized Medicine in Rare Diseases Open
View article: Rezension von: Müller, Ulrich; Wunderlich, Werner (Hrsg.), Herrscher, Helden, Heilige
Rezension von: Müller, Ulrich; Wunderlich, Werner (Hrsg.), Herrscher, Helden, Heilige Open
Ulrich Müller und Werner Wunderlich (Hrsg.): Herrscher - Helden - Heilige. (Mittelalter Mythen Band 1). UVK Fachverlag für Wissenschaft und Studium St. Gallen 1996. 781 Seiten. Gebunden DM 124,-
View article: Stimulated Raman histology for rapid intraoperative diagnosis prediction of spinal tumors with dural adhesion
Stimulated Raman histology for rapid intraoperative diagnosis prediction of spinal tumors with dural adhesion Open
View article: Shared decision making, diagnostic evaluation, and pharmacotherapy in type 2 diabetes
Shared decision making, diagnostic evaluation, and pharmacotherapy in type 2 diabetes Open
Current evidence continues to support the recommendations on pharmacotherapy of the 2021 guideline. The Guideline Group did not find evidence of adequate certainty to inform recommendations about the screening of persons at risk, HbA1c tar…
View article: Kardiovaskuläre Effektivität und Sicherheit neuer Antidiabetika – Relevanz der Studiendaten für die deutsche Versorgungsrealität bezüglich Alters- und Risikostruktur
Kardiovaskuläre Effektivität und Sicherheit neuer Antidiabetika – Relevanz der Studiendaten für die deutsche Versorgungsrealität bezüglich Alters- und Risikostruktur Open
Zusammenfassung Eine evidenzbasierte ärztliche Versorgung beruht auf den Ergebnissen von interventionellen klinischen Prüfungen. Seit Bekanntwerden des negativen Nutzen-Risiko-Verhältnisses der Thiazolidindione bei Menschen mit Typ-2-Diabe…
View article: POS1161 RITUXIMAB VS. COMBINATION OF RITUXIMAB AND CYCLOPHOSPHAMIDE INDUCTION THERAPY FOR ANCA-ASSOCIATED VASCULITIS: A RETROSPECTIVE STUDY
POS1161 RITUXIMAB VS. COMBINATION OF RITUXIMAB AND CYCLOPHOSPHAMIDE INDUCTION THERAPY FOR ANCA-ASSOCIATED VASCULITIS: A RETROSPECTIVE STUDY Open
View article: POS0150 AUTOANTIBODIES AGAINST FIBROBLAST GROWTH FACTOR (FGF-2), PLACENTAL GROWTH FACTOR (PLGF) AND BETA-ADRENERGIC RECEPTOR 1 (ADRB1) IN AN ALTERED NETWORK OF AUTOANTIBODIES IN SYSTEMIC SCLEROSIS
POS0150 AUTOANTIBODIES AGAINST FIBROBLAST GROWTH FACTOR (FGF-2), PLACENTAL GROWTH FACTOR (PLGF) AND BETA-ADRENERGIC RECEPTOR 1 (ADRB1) IN AN ALTERED NETWORK OF AUTOANTIBODIES IN SYSTEMIC SCLEROSIS Open
Background Autoantibodies (ab) against G protein-coupled receptors (GPCR), such as ab against angiotensin II receptor type 1 (AT1R), endothelin receptor type A (ETAR) or CXC chemokine receptor 3 and 4 (CXCR3/4) may contribute to the pathog…
View article: Implementation of 2D Barcode Medication Labels and Smart Pumps in Pediatric Acute Care: Lessons Learned
Implementation of 2D Barcode Medication Labels and Smart Pumps in Pediatric Acute Care: Lessons Learned Open
Background In pediatric intensive care, prescription, administration, and interpretation of drug doses are weight dependent. The use of standardized concentrations simplifies the preparation of drugs and increases safety. For safe administ…
View article: The Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitor Empagliflozin Reverses Hyperglycemia-Induced Monocyte and Endothelial Dysfunction Primarily through Glucose Transport-Independent but Redox-Dependent Mechanisms
The Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitor Empagliflozin Reverses Hyperglycemia-Induced Monocyte and Endothelial Dysfunction Primarily through Glucose Transport-Independent but Redox-Dependent Mechanisms Open
Purpose: Hyperglycaemia-induced oxidative stress and inflammation contribute to vascular cell dysfunction and subsequent cardiovascular events in T2DM. Selective sodium-glucose co-transporter-2 (SGLT-2) inhibitor empagliflozin significantl…
View article: Rezension von: Müller, Ulrich, Schwäbisch Gmünd unterm Hakenkreuz
Rezension von: Müller, Ulrich, Schwäbisch Gmünd unterm Hakenkreuz Open
Ulrich Müller, Schwäbisch Gmünd unterm Hakenkreuz, Schwäbisch Gmünd: einhorn- Verlag 2017. 208 S. ISBN 978-3-95747-063-8. € 19,80
View article: Frontmatter
Frontmatter Open
View article: Blood Sugar Targets in Surgical Intensive Care
Blood Sugar Targets in Surgical Intensive Care Open
Optimal blood sugar control for diabetic patients in intensive care meets the dual objectives of avoiding hypoglycemia while keeping the blood glucose concentration under 10 mmol/L (180 mg/dL). Nutrition therapy in accordance with the rele…
View article: Correction to: Salvation Expectations of Patients of Medicine, Complementary and Alternative Medicine and Religion
Correction to: Salvation Expectations of Patients of Medicine, Complementary and Alternative Medicine and Religion Open
View article: Metabolic control and hypoglycaemia in people with type 1 diabetes: insulin pump therapy vs. intensified insulin therapy in an unselected cohort in routine care
Metabolic control and hypoglycaemia in people with type 1 diabetes: insulin pump therapy vs. intensified insulin therapy in an unselected cohort in routine care Open
View article: OP0054 NEW ROLE FOR PROTEINASE 3 IN IL-16 BIOACTIVITY CONTROL IN GRANULOMATOSIS WITH POLYANGIITIS
OP0054 NEW ROLE FOR PROTEINASE 3 IN IL-16 BIOACTIVITY CONTROL IN GRANULOMATOSIS WITH POLYANGIITIS Open
View article: Diabetes related distress is high in inpatients with diabetes
Diabetes related distress is high in inpatients with diabetes Open
View article: Effectiveness and Safety of SGLT2 Inhibitors in Clinical Routine Treatment of Patients with Diabetes Mellitus Type 2
Effectiveness and Safety of SGLT2 Inhibitors in Clinical Routine Treatment of Patients with Diabetes Mellitus Type 2 Open
The aim of this study was to investigate the effectiveness of SGLT2 inhibitors with regard to metabolic parameters and patient safety under routine ambulatory conditions. Retrospective longitudinal study of 95 patients with type 2 diabetes…
View article: Is There a HbA1c Threshold for Symptoms of Chronic Hyperglycaemia?
Is There a HbA1c Threshold for Symptoms of Chronic Hyperglycaemia? Open
Aims of the study: The minimum therapeutic goals regarding metabolic control for people with diabetes mellitus is “absence of symptoms of hyperglycaemia”. However, it is uncertain, if a level of HbA1c can be defined which guarantees the ab…
View article: Salvation Expectations of Patients of Medicine, Complementary and Alternative Medicine and Religion
Salvation Expectations of Patients of Medicine, Complementary and Alternative Medicine and Religion Open
View article: Progression of Diabetic Complications in Subgroups of People with Long Term Diabetes Type 1 According to Clinical Course
Progression of Diabetic Complications in Subgroups of People with Long Term Diabetes Type 1 According to Clinical Course Open
Aims Prevention and prediction of microvascular complications are important aims of medical care in people with type 1 diabetes. Since the course of the disease is heterogenous, we tried to identify subgroups with specific risk profiles fo…
View article: FRI0001 NEUTROPHILS IN GRANULOMATOSIS WITH POLYANGIITIS DISPLAY FEATURES OF PYROPTOSIS
FRI0001 NEUTROPHILS IN GRANULOMATOSIS WITH POLYANGIITIS DISPLAY FEATURES OF PYROPTOSIS Open
View article: AB0166 IMMUNOGLOBULIN G DERIVED FROM PATIENTS WITH SYSTEMIC SCLEROSIS IMPRINTS A PRO-INFLAMMATORY AND PRO-FIBROTIC PHENOTYPE IN MONOCYTE-LIKE THP-1 CELLS
AB0166 IMMUNOGLOBULIN G DERIVED FROM PATIENTS WITH SYSTEMIC SCLEROSIS IMPRINTS A PRO-INFLAMMATORY AND PRO-FIBROTIC PHENOTYPE IN MONOCYTE-LIKE THP-1 CELLS Open
View article: THU0025 MICRO-RNA DIFFERENTIALLY REGULATE THE ALTERNATIVE PRTN3-MRNA IN GRANULOMATOSIS WITH POLYANGIITIS
THU0025 MICRO-RNA DIFFERENTIALLY REGULATE THE ALTERNATIVE PRTN3-MRNA IN GRANULOMATOSIS WITH POLYANGIITIS Open
View article: AB0159 INTERLEUKIN-16 PLAYS A ROLE IN THE PATHOGENESIS OF SYSTEMIC SCLEROSIS
AB0159 INTERLEUKIN-16 PLAYS A ROLE IN THE PATHOGENESIS OF SYSTEMIC SCLEROSIS Open
View article: AB0496 AUTOANTIBODIES TARGETING COMPLEMENT RECEPTORS 3A AND 5A1 ARE DECREASED IN ANCA-ASSOCIATED VASCULITIS AND CORRELATE WITH HIGHER RELAPSE RATE.
AB0496 AUTOANTIBODIES TARGETING COMPLEMENT RECEPTORS 3A AND 5A1 ARE DECREASED IN ANCA-ASSOCIATED VASCULITIS AND CORRELATE WITH HIGHER RELAPSE RATE. Open
View article: Epidermolysis bullosa aquista (EBA) with obliteration of the larynx – a case report
Epidermolysis bullosa aquista (EBA) with obliteration of the larynx – a case report Open
The acquired type of Epidermolysis bullosa with antibodies against collagen VII is a rare subepithelial blistering disease with a prevalence of two affected persons per 10 million people. Current literature reveals only seven cases with la…
View article: Epidermolysis bullosa aquista (EBA) mit Obliteration des Larynx – Ein Case report
Epidermolysis bullosa aquista (EBA) mit Obliteration des Larynx – Ein Case report Open
Die autoimmune Form der EBA – mit Antikörpern gegen Kollagen Typ VII der Basalmembranen – stellt eine sehr seltene blasenbildende Erkrankung mit einer Prävalenz von 2 auf 10 Millionen Menschen dar. In der Literatur sind nur sieben Fälle mi…